Previous 10 | Next 10 |
home / stock / xphyf / xphyf news
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / December 8, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY) (OTC:XPHYF) (FSE:4XT ) (" XPhyto " or the " Company "), is pleased to announce that it has close...
VANCOUVER, British Columbia, Dec. 08, 2020 (GLOBE NEWSWIRE) -- X P hyto Therapeutics Inc (OTCQB:XPHYF – CSE:XPHY), a next-generation bioscience accelerator based in Vancouver with operations in Germany, today announced that Hugh Rogers, CEO and Director, will pre...
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / December 3, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (" XPhyto " or the " Company "), is pleased to announce that it has reached...
Psilocybin, mescaline, LSD, MDMA, DMT and other psychedelic compounds added to exclusive dealing agreement for the development of psychedelic-based therapeutics VANCOUVER, BC / ACCESSWIRE / November 10, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (" XPhyto ...
Psilocybin, mescaline, LSD, MDMA, DMT and other psychedelic compounds added to exclusive dealing agreement for the development of psychedelic-based therapeutics VANCOUVER, BC / ACCESSWIRE / November 10, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (" XPhyto ...
Experienced pharma executive and consultant Per S. Thoresen joins board Advisory engagement with CorpCann AS strengthens Europe-focused strategy VANCOUVER, BC / ACCESSWIRE / November 5, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (" XPhyto " or the " C...
Experienced pharma executive and consultant Per S. Thoresen joins board Advisory engagement with CorpCann AS strengthens Europe-focused strategy VANCOUVER, BC / ACCESSWIRE / November 04, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (" XPhyto " or the " Company ...
Research agreement to investigate the feasibility of a proprietary biotechnology process for the industrial production of psilocybin API Psilocybin is designated by the FDA as a breakthrough therapy for severe depression VANCOUVER, BC / ACCESSWIRE / November 03, 2020 / XPhyto T...
25-minute RT-PCR lab test to complement 15-minute rapid test European market launch of both COVID-19 tests planned for Q1 2021 VANCOUVER, BC / ACCESSWIRE / October 28, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY)(OTC:XPHYF)(FSE:4XT ) (" XPhyto " or the " Company "), a next-ge...
VANCOUVER, BC / ACCESSWIRE / October 19, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY / OTCQB:XPHYF / FSE:4XT ) (" XPhyto " or the " Company "), a next-generation bioscience company, is pleased to announce an update on its third-party contract development programs. Over the past 12 month...
News, Short Squeeze, Breakout and More Instantly...
XPhyto Therapeutics Corp Company Name:
XPHYF Stock Symbol:
OTCMKTS Market:
VANCOUVER, BC / ACCESSWIRE / October 3, 2023 / BioNxt Solutions Inc. (" BioNxt " or the " Company ") (CSE:BNXT)(OTCQB:XPHYF)(FSE:4XT), announces that Per Thoresen and Peter Damouni have resigned as directors of the Company. The Company would like to thank Mr. Thoresen and Mr. Damouni for their c...
VANCOUVER, BC / ACCESSWIRE / September 28, 2023 / BioNxt Solutions Inc. (" BioNxt " or the " Company ") (CSE:BNXT)(OTCQB:BNXTF)(FSE:4XT) is pleased to announce that, further to its news releases dated August 4 and August 28, 2023, the Company has closed the second tranche of its non-brokered pri...
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / August 4, 2023 / BioNxt Solutions Inc. (" BioNxt " or the " Company ") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to announce a non-brokered private placement of u...